Concomitant Coronary Artery Disease and Lung Cancer
- 8 Downloads
It is common for patients presenting with a newly diagnosed lung mass to have concomitant coronary artery disease. The Society of Thoracic Surgeons database reports a 20.9% incidence rate of coronary artery disease in patients undergoing pulmonary resection for primary lung cancer. These two conditions have multiple coinciding risk factors, including increased age, tobacco use, and lifestyle. As a result, a high overlap of patients with concomitant disease is expected. This cohort of patients presents a significant challenge for decision-making and therapeutic intervention as there is no consensus on how to best treat this patient population. This chapter attempts to address issues such as the choice between a one- or two-stage procedure, the use of extracorporeal circulation for myocardial revascularization, the choice of incision and the extent of pulmonary resection.
KeywordsCoronary artery disease Lung cancer Lung resection Off-pump coronary artery bypass grafting Surgery
- 3.Waller D. Thoracic intervention & surgery to cure lung cancer: margin not lobe is the new gold standard. J R Soc Med. 2018;2018:141076818775078.Google Scholar
- 13.Fu Q, Li QZ, Liang D, Ruan XH, Wang ZX, Wei MX. Early and long-term results of combined cardiac surgery and neoplastic resection in patients with concomitant severe heart disease and neoplasms. Chin Med J (Engl). 2011;124:1939–42.Google Scholar